Richard J. Lewis
Corporate Officer/Principal presso The University of Queensland
Profilo
Richard J.
Lewis was the founder of Xenome Ltd.
which was founded in 2000, where he held the title of Chief Scientific Officer from 2000 to 2011.
Currently, he holds the title of Principal at The University of Queensland and National Health & Medical Research Council.
In the past, he held the title of Principal at Molecular Pharmacology (USA) Ltd.
Posizioni attive di Richard J. Lewis
| Società | Posizione | Inizio |
|---|---|---|
| The University of Queensland | Corporate Officer/Principal | 01/07/2009 |
| National Health & Medical Research Council | Corporate Officer/Principal | 01/07/2009 |
Precedenti posizioni note di Richard J. Lewis
| Società | Posizione | Fine |
|---|---|---|
| MOLECULAR PHARMACOLOGY (USA), LTD. | Corporate Officer/Principal | - |
Xenome Ltd.
 Xenome Ltd. Pharmaceuticals: MajorHealth Technology Xenome Ltd. discovered and developed peptide pharmaceuticals. Its product, Xen2174, was a novel conopeptide analogue for the treatment of severe pain. The company was founded in 2008 and was headquartered in Indooroopilly, Australia. | Fondatore | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| MOLECULAR PHARMACOLOGY (USA), LTD. | Commercial Services |
| Aziende private | 2 |
|---|---|
Xenome Ltd.
Xenome Ltd. Pharmaceuticals: MajorHealth Technology Xenome Ltd. discovered and developed peptide pharmaceuticals. Its product, Xen2174, was a novel conopeptide analogue for the treatment of severe pain. The company was founded in 2008 and was headquartered in Indooroopilly, Australia. | Health Technology |
| National Health & Medical Research Council | Government |
- Borsa valori
- Insiders
- Richard J. Lewis